Neutropenic Enterocolitis Associated with Docetaxel-based Chemotherapy in a Patient with Breast Carcinoma

Year 2016, Volume: 7 Issue: 3, 51 - 52, 01.07.2016

Haldun Kar Necat Cin Özgün Akgül Cengiz Tavusbay Yasin Peker Fatma Tatar

Abstract

Introduction: Neutropenic enterocolitis (NE) is a rare but often life-threatening complication associated with taxane-based chemotherapy in patients with cancer. Case Report: A 39-year-old woman with a diagnosis of breast carcinoma underwent breast conserving surgery for the right breast. She was treated with docetaxel, cyclophosphamide, and epirubicin for the following months. Seven days after receiving the first dose of chemotherapy, she was presented to our emergency center with diarrhea, vomiting, fever, and diffuse abdominal pain. Abdominal examination revealed right lower quadrant tenderness with rebound. Blood work revealed severe neutropenia and leucopenia. Computed tomography demonstrated thickening of the walls of the ascending and transverse colon. Furthermore, emergency laparotomy revealed a necrotic hepatic flexura without perforation. Right hemicolectomy was performed; the biopsy revealed acute hemorrhagic infarction of the colon. Conclusion: Patients with breast carcinoma presenting with acute abdominal pain, neutropenia, and radiologically demonstrable bowel wall thickening while receiving taxane-based chemotherapy should be suspected of having NE

Keywords

Neutropenic enterocolitis, docetaxel, chemotherapy

References

• Li Z, Ibrahim NK, Wathen JK, Wang M, Mante Menchu RP, Valero V, et al. Colitis in patients with breast carcinoma treated with taxane-based chemotherapy. Cancer 2004; 101: 1508-13. [CrossRef]
• Rolston KV. Neutropenic Enterocolitis Associated with Docetaxel Therapy in a Patient with Breast Cancer. Clin Adv Hematol Oncol 2009; 7: 527-8.
• Nesher L, Rolston KV. Neutropenic Enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis 2013; 56: 711-7. [CrossRef]
• Ullery BW, Pieracci FM, Rodney JRM, Barie PS. Neutropenic Enterocolitis. Surg Infect (Larchmt) 2009; 10: 307-14. [CrossRef]
• Hussein MA, Bird BR, O’Sullivan MJ, Kalimuthu SG, O’Sullivan GC, O’Reilly S et al. Symptoms in cancer patients and an unusual tumor: Case 2. Docetaxel- related ischemic colitis. J Clin Oncol 2005; 23: 9424-5. [CrossRef]
• Dumitra S, Sideris L, Leclerc Y, Leblanc G, Dube P. Neutropenic enterocolitis and docetaxel neoadjuvant chemotherapy. Ann Oncol 2009; 20: 795-6. [CrossRef]
• Sezer O, Eucker J, Possinger K. Colitis associated with docetaxel-based chemotherapy. Lancet 2000; 355: 1823-4. [CrossRef]
• Machado NO. Neutropenic enterocolitis: A continuing medical and sur- gical challenge. N Am J Med Sci 2010; 2: 293-300.
• Sodhi KS, Aiyappan SK, Singh G, Prakash M, Khandelwal N. Colitis and colonic perforation in a patient with breast carcinoma treated with tax- ane based chemotherapy. Indian J Cancer 2011; 48: 134-5. [CrossRef]
• Badgwell BD, Cormier JN, Wray CJ, Borthakur G, Qiao W, Rolston KV, et al. Challenges in surgical management of abdominal pain in the neu- tropenic cancer patient. Ann Surg 2008; 248: 104-109. [CrossRef] 52